MAPT and frontotemporal dementia: Plasma tau phosphorylated at threonine 217 (p-tau217) was also proved to differentiate diagnosis of Alzheimer's disease syndromes from frontotemporal lobar degeneration (FTLD) syndromes, as an indication of amyloid-PET-positivity, and to have stronger correlations with tau-PET signal [34].